Investigational testing for zika virus among U.S. Blood donors

New England Journal of Medicine

Volumn 378, Issue 19, 2018, Pages 1778-1788

  Saá, Paula ^a   Proctor, Melanie ^a   Foster, Gregory ^a   Krysztof, David ^a   Winton, Colleen ^a   Linnen, Jeffrey M ^b   Gao, Kui ^b   Brodsky, Jaye P ^c   Limberger, Ronald J ^d   Dodd, Roger Y ^a   Stramer, Susan L ^a  

^a AMERICAN RED CROSS   (United States)

^b Grifols Diagnostic Solutions Inc   (United States)

^c Quality Analytics   (United States)

^d WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA; ZIKA VIRUS VACCINE; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ERYTHROCYTE COUNT; EXPERIMENTAL STUDY; FEMALE; FLORIDA; GENE AMPLIFICATION; HEALTH CARE COST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NONHUMAN; NUCLEIC ACID ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RED CROSS; REPEAT PROCEDURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA TRANSCRIPTION; SEROLOGY; TRAVEL; UNITED STATES; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS TRANSMISSION; YOUNG ADULT; ZIKA FEVER; ZIKA VIRUS; BLOOD; CLINICAL TRIAL; ECONOMICS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

ADULT; AGED; BLOOD; BLOOD DONORS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MASS SCREENING; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RED CROSS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRAL LOAD; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85046961659     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1714977     Document Type: Article

References (40)

1. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952;46: 509-20.
2. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-9.
3. Cao-Lormeau VM, Roche C, Teissier A, et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 2014;20: 1085-6.
4. Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 1969;18:411-5.
5. Grard G, Caron M, Mombo IM, et al. Zika virus in Gabon (Central Africa) — 2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis 2014;8(2):e2681.
6. Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014;19:20751.
7. Calvet G, Aguiar RS, Melo ASO, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016;16:653-60.
8. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016;374:951-8.
9. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects — reviewing the evidence for causality. N Engl J Med 2016;374:1981-7.
10. Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.
11. Motta IJF, Spencer BR, Cordeiro da Silva SG, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 2016;375:1101-3.
12. Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014;19:20761.
13. Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880-2.
14. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected female-to-male sexual transmission of Zika virus — New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65:716-7.
15. Gallian P, Cabié A, Richard P, et al. Zika virus in asymptomatic blood donors in Martinique. Blood 2017;129:263-6.
16. Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WT, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy — Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:242-7.
17. Soares CN, Brasil P, Carrera RM, et al. Fatal encephalitis associated with Zika virus infection in an adult. J Clin Virol 2016;83:63-5.
18. Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningo-encephalitis. N Engl J Med 2016;374: 1595-6.
19. Rozé B, Najioullah F, Signate A, et al. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. Euro Surveill 2016;21:30205.
20. Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet 2016;387:1481.
21. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome — case report, French Polynesia, December 2013. Euro Surveill 2014;19:20720.
22. Paploski IA, Prates AP, Cardoso CW, et al. Time lags between exanthematous illness attributed to Zika virus, Guillain-Barre Syndrome, and microcephaly, Salvador, Brazil. Emerg Infect Dis 2016;22: 1438-44.
23. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531-9.
24. Chevalier MS, Biggerstaff BJ, Basavaraju SV, et al. Use of blood donor screening data to estimate Zika virus incidence, Puerto Rico, April-August 2016. Emerg Infect Dis 2017;23:790-5.
25. Food and Drug Administration. Donor screening recommendations to reduce the risk of transmission of Zika virus by human cells, tissues, and cellular and tissue-based products. 2016 (https://www.fda.gov/downloads/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/ guidances/tissue/ucm488582.pdf).
26. Food and Drug Administration. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components. 2016 (https://www.fda.gov/downloads/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/ guidances/blood/ucm518213.pdf).
27. Williamson PC, Linnen JM, Kessler DA, et al. First cases of Zika virus-infected US blood donors outside states with areas of active transmission. Transfusion 2017; 57:770-8.
28. Gao K, James A, Green T, et al. Performance and evaluation of Procleix Zika virus assay on the fully automated Procleix Panther System. Presented at the 27th Regional Congress of the ISBT, Copenhagen, June 17–21, 2017. abstract.
29. St George K, Sohi IS, Dufort EM, et al. Zika virus testing considerations: lessons learned from the first 80 real-time reverse transcription-PCR-positive cases diagnosed in New York State. J Clin Microbiol 2017; 55:535-44.
30. Zika MAC-ELISA. Atlanta: Centers for Disease Control and Prevention, 2017 (https://www.fda.gov/downloads/medicaldevices/safety/emergencysituations/ UCM488044.pdf).
31. Ellingson KD, Sapiano MRP, Haass KA, et al. Cost projections for implementation of safety interventions to prevent transfusion-transmitted Zika virus infection in the United States. Transfusion 2017;57:Suppl 2:1625-33.
32. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536-43.
33. Galel SA, Williamson PC, Busch MP, et al. First Zika-positive donations in the continental United States. Transfusion 2017;57:762-9.
34. Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion 2017; 57:850-6.
35. Modjarrad K, Lin L, George SL, et al. Preliminary aggregate safety and immu-nogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Lancet 2017;391:563-71.
36. Rios M, Daniel S, Chancey C, Hewlett IK, Stramer SL. West Nile virus adheres to human red blood cells in whole blood. Clin Infect Dis 2007;45:181-6.
37. Froeschl G, Huber K, von Sonnenburg F, et al. Long-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case report. BMC Infect Dis 2017;17:55.
38. Paz-Bailey G, Rosenberg ES, Doyle K, et al. Persistence of Zika virus in body fluids — preliminary report. N Engl J Med 2017. DOI: 10.1056/NEJMoa1613108.
39. Klein HG, Hrouda JC, Epstein JS. Crisis in the sustainability of the U.S. blood system. N Engl J Med 2017;377: 1485-8.
40. Dodd RY, Foster GA, Stramer SL. Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfus Med Rev 2015;29: 153-61.